ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,423.20
      0.11%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.785
      1.05%
      Bitcoin
      65,063.40
      -2.14%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      06/16/20234:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/16/20234:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/16/20234:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/15/20234:57PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      06/15/20232:30PMGlobeNewswire Inc.Esperion Presents Results from New Analysis on Cardiovascular Benefits with Bempedoic Acid Treatment at ENDO 2023NASDAQ:ESPREsperion Therapeutics Inc
      06/08/20231:26PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      06/08/20238:00AMGlobeNewswire Inc.Esperion to Present New Key Science at the American Diabetes Association’s 83rd Scientific Sessions 2023NASDAQ:ESPREsperion Therapeutics Inc
      06/05/20238:00AMGlobeNewswire Inc.Esperion to Present Additional Analyses from the Landmark CLEAR Outcomes Study at ENDO 2023NASDAQ:ESPREsperion Therapeutics Inc
      06/01/20238:00AMGlobeNewswire Inc.Esperion Announces Submission of Supplemental New Drug Applications to U.S. FDA for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) TabletNASDAQ:ESPREsperion Therapeutics Inc
      05/25/20234:30PMGlobeNewswire Inc.Esperion Announces Adjournment of 2023 Annual Meeting of StockholdersNASDAQ:ESPREsperion Therapeutics Inc
      05/24/20238:00AMGlobeNewswire Inc.Esperion to Participate in Jefferies Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      05/18/20234:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      05/17/20234:40PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ESPREsperion Therapeutics Inc
      05/12/20234:30PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      05/11/20234:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      05/10/20234:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      05/09/20239:01AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ESPREsperion Therapeutics Inc
      05/09/20237:23AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      05/09/20237:00AMGlobeNewswire Inc.Esperion Reports First Quarter 2023 Financial ResultsNASDAQ:ESPREsperion Therapeutics Inc
      05/04/20238:30AMGlobeNewswire Inc.Esperion Retains Gibson Dunn to Secure $300 Million Payment From DSE; Will Announce First Quarter Financial Results Tuesday, May 9NASDAQ:ESPREsperion Therapeutics Inc
      05/01/20238:00AMGlobeNewswire Inc.Esperion to Participate in JMP Securities Life Sciences ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      04/27/20238:00AMGlobeNewswire Inc.Esperion to Participate in Bank of America Securities 2023 Health Care ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      04/25/20238:00AMGlobeNewswire Inc.Esperion to Report First Quarter 2023 Financial Results May 9, 2023NASDAQ:ESPREsperion Therapeutics Inc
      04/20/20234:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      04/20/20234:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      04/19/20234:14PMEdgar (US Regulatory)Amended Report of Proposed Sale of Securities (144/a)NASDAQ:ESPREsperion Therapeutics Inc
      04/19/20233:39PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ESPREsperion Therapeutics Inc
      04/19/20233:25PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ESPREsperion Therapeutics Inc
      04/19/20233:23PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ESPREsperion Therapeutics Inc
      04/19/20238:42AMGlobeNewswire Inc.Esperion Announces Co-Promotion Agreement With Currax Pharmaceuticals LLCNASDAQ:ESPREsperion Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ESPR